An immunoinformatics-based multi-epitope vaccine candidate confers cross-protection against two Actinobacillus pleuropneumoniae serovars. Tan L, Fang Y, Liu P, Su M, et al. Vaccine 2026;91:129104.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tan L, Fang Y, Liu P, Su M, et al. An immunoinformatics-based multi-epitope vaccine candidate confers cross-protection against two Actinobacillus pleuropneumoniae serovars. Vaccine 2026;91:129104.
PMID: 42673711